Clinical Trials Browser

Phase 1/2 × Head and Neck Neoplasms × Cetuximab × Clear all

NCT02643550 2023-05-12

Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Phase 1/2 Completed

Head and Neck Neoplasms

NCT00660218 2021-11-08

A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer

Phase 1/2 Completed

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00851877 2020-08-21

Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer

Phase 1/2 Completed

37 enrolled 9 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT01009346 2018-07-17

RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN

Phase 1/2 Terminated

9 enrolled 9 charts

Head and Neck Neoplasms

NCT03051906 2017-11-22

DUCRO-HN

Phase 1/2 Unknown

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00704639 2017-07-12

Chemoradiation Treatment for Head and Neck Cancer

Phase 1/2 Completed

Head and Neck Neoplasms

NCT00927147 2017-01-31

Boron Neutron Capture Therapy (BNCT) Combined With Cetuximab in the Treatment of Locally Recurred Head and Neck Cancer

Phase 1/2 Terminated

Head and Neck Neoplasms

NCT02143622 2016-04-21

Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma Patients

Phase 1/2 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01283334 2014-12-04

A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer

Phase 1/2 Completed

20 enrolled 8 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00714649 2012-11-14

CHIRON

Phase 1/2 Completed

Head and Neck Neoplasms

NCT01166035 2010-07-20

TEXO

Phase 1/2 Unknown

GastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms